TAKEDA PARTNERS WITH WESTWOOD & WILSHIRE TO FILL MEDICAL DIRECTOR, MEDICAL AFFAIRS

Dr. Gregory Ursino has joined Takeda as their new Medical Director, Medical Affairs – Hematology Oncology. Dr. Ursino joins Takeda from Bristol-Myers Squibb, where he served as their Medical Director of Medical Affairs – Health Systems. In addition to his Residency in Obstetrics and Gynecology at the University of Rochester, Dr. Ursino has held positions of increasing related responsibility at United Health Group, Novartis AG, Glaxo Smith Kline, and Blue Cross Blue Shield throughout his career.

The search was successfully led by Michael Cane at Westwood & Wilshire.

At Westwood & Wilshire, we recognize that people are an organization's top asset. We are passionate about delivering premier talent to the world’s most innovative companies. We are particularly focused on companies ranging from VC-backed start-ups to mid-sized commercial entities and our assignments range from C-Suite to mid-management. Based in Los Angeles, California with additional offices in Silicon Valley, we serve our clients on a local, national and global basis.

Previous
Previous

JAZZ PHARMACEUTICALS PARTNERS WITH WESTWOOD & WILSHIRE TO FILL SENIOR MEDICAL DIRECTOR OF CLINICAL DEVELOPMENT

Next
Next

BAXTER PARTNERS WITH WESTWOOD & WILSHIRE TO FILL GLOBAL MEDICAL DIRECTOR, CLINICAL DEVELOPMENT STRATEGY LEAD